Target intelligence / Profile preview

microRNA 4284 (miR-4284)

Target
miR-4284
Molecular classification
MicroRNA, Non-coding RNA, Other
01

Overview

microRNA 4284 (miR-4284) is a small, non-coding RNA molecule involved in the post-transcriptional regulation of gene expression. It functions predominantly as a tumor suppressor in multiple cancer types, including renal cell carcinoma and glioblastoma, where it suppresses cell proliferation, induces apoptosis, and inhibits migration and invasion by targeting genes such as glutamate decarboxylase 1 (GAD1). miR-4284 is downregulated in several cancers and may serve as a diagnostic and prognostic biomarker. Small molecule agents such as DET, DETD-35, and BBMD3 can modulate miR-4284 expression and anti-cancer activity. miR-4284 also participates in the regulation of mitochondrial function and cellular oxidative stress responses, with implications for tumor progression and therapeutic response[1][2][4][5].

Other names
hsa-miR-4284MIR4284mir-4284
02

Mechanism of action

Induction of apoptosis and inhibition of proliferation through upregulation of miR-4284 by BBMD3 and other small molecules. Suppression of cell viability, tumorigenic features, and metastasis through direct targeting of specific mRNAs (e.g., GAD1). Regulation of mitochondrial proton leak and oxidative stress in cancer cells.

03

Biological functions

Regulation of gene expressionTumor suppressionInduction of apoptosisInhibition of cell proliferationRegulation of cell migration and invasionRegulation of mitochondrial function and oxidative stress response
04

Disease associations

Cancer (including renal cell carcinoma, diffuse large B-cell lymphoma, glioblastoma, triple-negative breast cancer, non-small cell lung cancer, gastric cancer, ovarian cancer)Other (potential diagnostic and prognostic biomarker)
05

Safety considerations

As a nucleic acid-based therapeutic target, safety concerns include off-target effects, delivery and stability challenges, potential immunogenicity, and regulation complexity typical of microRNAsNo specific adverse effects reported for miR-4284 therapies in current preclinical literature
06

Interacting drugs

Deoxyelephantopin (DET)

2 more in the full profile.

07

Biomarkers

Potential biomarker for diffuse large B-cell lymphomaCandidate biomarker in renal cell carcinoma for prognosis, diagnosis, and therapy monitoring

Beyond the preview

Go deeper on microRNA 4284 (miR-4284).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on microRNA 4284 (miR-4284).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call